ITM to Host Virtual Symposium at the ESMO Congress 2021 with Key Neuroendocrine Tumor Experts

09.17.2021 10:30 am - 12:00 pm


MUNICH & GARCHING, Germany--(BUSINESS WIRE)--ITM AG, a leading radiopharmaceutical company, today announced that it will host a virtual industry satellite symposium titled, “A Global Perspective on the Management of Neuroendocrine Tumors – the Evolving Role of Targeted Radionuclide Diagnostics and Therapy” at the European Society of Medical Oncology (ESMO) Congress 2021. The symposium will feature renowned key opinion leaders in the field and will be held on Friday, September 17th, 2021, from 10:30 am - 12:00 pm CEST on channel 3, open to ESMO registered participants.